53 research outputs found

    Consanguinity in Two Spanish Regions: La Cabrera and Fuentes Carrionas. Dispensations and Isonymy

    Get PDF
    In this work the level and structure of consanguinity is analysed in two Spanish rural regions of similar geographic and orographic characteristics for the period between 1880 and 1979, employing two different methodologies. The estimates according dispensations shows that the total levels (a4=0.00552 in La Cabrera and 0.00405 in Fuentes Carrionas) and the structures of consanguinity (C22/C33=0.43 and 0.34) are similar in both regions, but have evolved differently. Whereas in La Cabrera both parameters have remained stable, in Fuentes Carrionas they fluctuated through the period analysed. On studying the structure of consanguinity more closely using the isonymic method, it can be seen that in La Cabrera total consanguinity (Ft=0.0206) should be attributed mainly to environmental factors (Fr=0.0193) and to a lesser extent to socio-cultural factors (Fn=0.0013), whereas in Fuentes Carrionas it derives, almost exclusively, from the former (Ft=0.01270; Fr=0.01589; Fn=-0.00325)

    Gamificación como apoyo al aprendizaje en la enseñanza pråctica en biología

    Get PDF
    Memoria ID2022-... Ayudas de la Universidad de Salamanca para la innovaciĂłn docente, curso 2022-2023

    Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic Study

    Get PDF
    [EN] Despite being clinically underestimated, sexual dysfunction (SD) is one of the most frequent and lasting adverse effects associated with antidepressants. Desvenlafaxine is an antidepressant (AD) with noradrenergic and serotonergic action that can cause a lower SD than other serotonergic ADs although there are still few studies on this subject. Objective: To check the frequency of SD in two groups of depressive patients: one group was desvenlafaxine-naïve; the other was made up of patients switched to desvenlafaxine from another AD due to iatrogenic sexual dysfunction. A naturalistic, multicenter, and prospective study of patients receiving desvenlafaxine (50–100 mg/day) was carried out on 72 patients who met the inclusion criteria (>18 years old and sexually active), who had received desvenlafaxine for the first time (n = 27) or had switched to desvenlafaxine due to SD with another AD (n = 45)

    Risk factors for eating disorders in students of the University of Manizales

    Get PDF
    Determinar la frecuencia de los factores de riesgo para trastornos de la alimentaciĂłn en estudiantes de la Universidad de Manizales. Materiales y mĂ©todos: De 3,610 estudiantes regulares de la Universidad de Manizales se tomĂł una muestra de 165 estudiantes, quienes respondieron un cuestionario integrado compuesto por variables demogrĂĄficas, las escalas de Zung para ansiedad o depresiĂłn, el Eating Disorderrs Inventory (EDI2) y el Apgar familiar; ademĂĄs se tomaron las medidas de peso, talla, Índice de masa corporal y pliegue en el antebrazo. Resultado: Un12.7% de la poblaciĂłn presentĂł factor de riesgo positivo para trastornos de la conducta alimentarĂ­a, 17.3% de la poblaciĂłn femenina y el 3.8% de la poblaciĂłn masculina; las personas con mayor factor de riesgo fueron las mujeres en la facultad de ComunicaciĂłn Social y Periodismo (24.1%). Se determinĂł una relaciĂłn significativa entre la variable impulso por la delgadez con la ansiedad o depresiĂłn. El mayor Índice de masa corporal y de porcentaje de grasa estĂĄ asociado con un aumento en la variable impulso por la delgadez. Conclusiones :Se encontraron factores de riesgo asociados con trastornos de la alimentaciĂłn. La frecuencia del factor de riesgo segĂșn EDI2 en este estudio fue mĂĄs baja que la encontrada en estudios realizados en MedellĂ­n y BogotĂĄ.[Cano AA, Castaño JJ, Corredor DA, GarcĂ­a AM, GonzĂĄlez M, Lloreda OL, et al. Factores de riesgo para trastornos de la alimentaciĂłn en los alumnos de la Universidad de Manizales. MedUNAB 2007; 10:187-194]To determine the frequency of risk factors for eating disorders in students at the University of Manizales. Materials and methods: A sample of 165 students was taken from 3,610 regular students of the University of Manizales, who answered an integrated questionnaire made up of demographic variables, the Zung scales for anxiety or depression, the Eating Disorders Inventory (EDI2) and the Apgar. familiar; in addition, measurements of weight, height, body mass index and fold in the forearm were taken. Result: 12.7% of the population presented a positive risk factor for eating disorders, 17.3% of the female population and 3.8% of the male population; the people with the highest risk factor were women in the Faculty of Social Communication and Journalism (24.1%). A significant relationship was determined between the variable drive for thinness with anxiety or depression. Higher body mass index and body fat percentage are associated with an increase in the drive for thinness variable. Conclusions: Risk factors associated with eating disorders were found. The frequency of the risk factor according to EDI2 in this study was lower than that found in studies carried out in MedellĂ­n and BogotĂĄ.[Cano AA, Castaño JJ, Corredor DA, GarcĂ­a AM, GonzĂĄlez M, Lloreda OL, et al. Risk factors for eating disorders in students of the University of Manizales. MedUNAB 2007; 10:187-194

    Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Get PDF

    Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    Get PDF
    Altres ajuts: Fondo Europeo de Desarrollo Regional (FEDER), "A way of making Europe".Copy number (CN) polymorphisms of complement C4 play distinct roles in many conditions, including immune-mediated diseases. We investigated the association of C4 CN with systemic sclerosis (SSc) risk. Imputed total C4, C4A, C4B, and HERV-K CN were analyzed in 26,633 individuals and validated in an independent cohort. Our results showed that higher C4 CN confers protection to SSc, and deviations from CN parity of C4A and C4B augmented risk. The protection contributed per copy of C4A and C4B differed by sex. Stronger protection was afforded by C4A in men and by C4B in women. C4 CN correlated well with its gene expression and serum protein levels, and less C4 was detected for both in SSc patients. Conditioned analysis suggests that C4 genetics strongly contributes to the SSc association within the major histocompatibility complex locus and highlights classical alleles and amino acid variants of HLA-DRB1 and HLA-DPB1 as C4-independent signals

    Handbook of Active Ageing and Quality of Life: From Concepts to Applications

    Get PDF
    La ediciĂłn de este libro estuvo a cargo de Fermina Rojo-PĂ©rez y Gloria FernĂĄndez-Mayoralas.El documento adjunto contiene la cubierta, portada e Ă­ndice del libro.This handbook presents an overview of studies on the relationship of active ageing and quality of life. It addresses the new challenges of ageing from the paradigm of positive ageing (active, healthy and successful) for a better quality of life. It provides theoretical perspectives and empirical studies, including scientific knowledge as well as practical experiences about the good ageing and the quality of later life around the world, in order to respond to the challenges of an aged population. The handbook is structured in 4 sections covering theoretical and conceptual perspectives, social policy issues and research agenda, methods, measurement instrument-scales and evaluations, and lastly application studies including domains and geographical contexts.Peer reviewe

    Capitulo 2. Ciencias Naturales y Ciencias BĂĄsicas, IngenierĂ­a y TecnologĂ­a

    Get PDF
    La diseminaciĂłn de la LevitaciĂłn MagnĂ©tica, a pesar de lo antiguo de su tecnologĂ­a, ha sido limitada. Debido a sus inconvenientes prĂĄcticos de implementaciĂłn, su uso es bastante restringido, comparado con otras tecnologĂ­as (SCMaglev japonĂ©s, Transrapid alemĂĄn, o productos comerciales para ocio y entretenimiento). Con el boom de las tecnologĂ­as limpias y amigables con el medio ambiente y en concordancia con los objetivos del milenio, es pertinente plantearse el objetivo de optimizar el proceso de LevitaciĂłn MagnĂ©tica para generar un aprovechamiento de las ventajas de esta tecnologĂ­a a nivel mecĂĄnico, elĂ©ctrico, y ambiental.  Actualmente la UNAD adelanta un proyecto de investigaciĂłn cuyo objetivo es generar un modelo fĂ­sico matemĂĄtico de levitaciĂłn magnĂ©tica para aplicaciones en ingenierĂ­a. De este proyecto se ha derivado una primera revisiĂłn sistemĂĄtica de los principios fĂ­sicos y los modelos vigentes en LevitaciĂłn MagnĂ©tica

    Canagliflozin and renal outcomes in type 2 diabetes and nephropathy

    Get PDF
    BACKGROUND Type 2 diabetes mellitus is the leading cause of kidney failure worldwide, but few effective long-term treatments are available. In cardiovascular trials of inhibitors of sodium–glucose cotransporter 2 (SGLT2), exploratory results have suggested that such drugs may improve renal outcomes in patients with type 2 diabetes. METHODS In this double-blind, randomized trial, we assigned patients with type 2 diabetes and albuminuric chronic kidney disease to receive canagliflozin, an oral SGLT2 inhibitor, at a dose of 100 mg daily or placebo. All the patients had an estimated glomerular filtration rate (GFR) of 30 to <90 ml per minute per 1.73 m2 of body-surface area and albuminuria (ratio of albumin [mg] to creatinine [g], >300 to 5000) and were treated with renin–angiotensin system blockade. The primary outcome was a composite of end-stage kidney disease (dialysis, transplantation, or a sustained estimated GFR of <15 ml per minute per 1.73 m2), a doubling of the serum creatinine level, or death from renal or cardiovascular causes. Prespecified secondary outcomes were tested hierarchically. RESULTS The trial was stopped early after a planned interim analysis on the recommendation of the data and safety monitoring committee. At that time, 4401 patients had undergone randomization, with a median follow-up of 2.62 years. The relative risk of the primary outcome was 30% lower in the canagliflozin group than in the placebo group, with event rates of 43.2 and 61.2 per 1000 patient-years, respectively (hazard ratio, 0.70; 95% confidence interval [CI], 0.59 to 0.82; P=0.00001). The relative risk of the renal-specific composite of end-stage kidney disease, a doubling of the creatinine level, or death from renal causes was lower by 34% (hazard ratio, 0.66; 95% CI, 0.53 to 0.81; P<0.001), and the relative risk of end-stage kidney disease was lower by 32% (hazard ratio, 0.68; 95% CI, 0.54 to 0.86; P=0.002). The canagliflozin group also had a lower risk of cardiovascular death, myocardial infarction, or stroke (hazard ratio, 0.80; 95% CI, 0.67 to 0.95; P=0.01) and hospitalization for heart failure (hazard ratio, 0.61; 95% CI, 0.47 to 0.80; P<0.001). There were no significant differences in rates of amputation or fracture. CONCLUSIONS In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years
    • 

    corecore